ALHC vs CNC vs MOH vs CVS vs HUM

For growth investors, Alignment Healthcare, Inc.

(ALHC) is the stronger pick with 46. 1% revenue growth year-over-year, versus 7. 8% for CVS Health Corporation (CVS). Molina Healthcare, Inc. (MOH) offers the better valuation at 21. 5x trailing P/E (38. 3x forward), making it the more compelling value choice. Analysts rate Alignment Healthcare, Inc. (ALHC) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Molina Healthcare, Inc.

(MOH) is the cheapest at 21. 5x versus CVS Health Corporation at 58. 1x. On forward P/E, CVS Health Corporation is actually cheaper at 12. 1x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, CVS Health Corporation (CVS) delivered a total return of +11.

9%, compared to -44. 3% for Humana Inc. (HUM). Over 10 years, the gap is even starker: MOH returned +334. 0% versus CVS's +3. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Molina Healthcare, Inc.

(MOH) is the lower-risk stock at -0. 04β versus Alignment Healthcare, Inc. 's 0. 75β — meaning ALHC is approximately -2145% more volatile than MOH relative to the S&P 500. On balance sheet safety, Humana Inc. (HUM) carries a lower debt/equity ratio of 73% versus 189% for Alignment Healthcare, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Alignment Healthcare, Inc.

(ALHC) is pulling ahead at 46. 1% versus 7. 8% for CVS Health Corporation (CVS). On earnings-per-share growth, the picture is similar: Alignment Healthcare, Inc. grew EPS 99. 4% year-over-year, compared to -315. 8% for Centene Corporation. Over a 3-year CAGR, ALHC leads at 40. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Molina Healthcare, Inc.

(MOH) is the more profitable company, earning 1. 0% net margin versus -3. 4% for Centene Corporation — meaning it keeps 1. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CVS leads at 2. 6% versus -3. 9% for CNC. At the gross margin level — before operating expenses — HUM leads at 14. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, CVS Health Corporation (CVS) trades at 12.

1x forward P/E versus 140. 1x for Alignment Healthcare, Inc. — 128. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ALHC: 35. 7% to $24. 83.

In this comparison, CVS (3.

3% yield), HUM (1. 5% yield) pay a dividend. ALHC, CNC, MOH do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, CVS Health Corporation (CVS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

05), 3. 3% yield). Both have compounded well over 10 years (CVS: +3. 9%, ALHC: +4. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: ALHC is a small-cap high-growth stock; CNC is a mid-cap high-growth stock; MOH is a mid-cap quality compounder stock; CVS is a mid-cap income-oriented stock; HUM is a mid-cap quality compounder stock. CVS, HUM pay a dividend while ALHC, CNC, MOH do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.